Natalie Engelken
Family · Jonesboro, ARNPI 1417400656
Payments from drug & device makers
Across 58 payments — averaging $17.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$254
- Pfizer$143
- AstraZeneca$90
- Sanofi Pasteur Inc.$66
- Merck$54
- Novo Nordisk$50
- plus $378 from 17 others
What the payments were for
- Food & beverage$1,035100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $254 |
| Pfizer | 8 | $143 |
| AstraZeneca | 5 | $90 |
| Sanofi Pasteur Inc. | 3 | $66 |
| Merck | 3 | $54 |
| Novo Nordisk | 3 | $50 |
| Biogen | 2 | $44 |
| GSK | 2 | $39 |
| Cepheid | 1 | $34 |
| Sunovion Pharmaceuticals Inc. | 3 | $33 |
| Vertex | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Corium, LLC | 1 | $25 |
| Boston Scientific | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
| Mayne Pharma Commercial LLC | 1 | $7 |
How this compares
$1,035 in reported general payments places this provider in the 70th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $336 |
| Azithromycin | 23 | $101 |
| Dexamethasone | 11 | $49 |
| Prednisone | 15 | $10 |
Paid to pharmacies, not to this prescriber.
Other family in Jonesboro
- Stefanie BrackinJonesboro$51K
- Jessica MatthewsJonesboro$19K
- Kimberly DanielsJonesboro$14K
- Kimberly RoddyJonesboro$12K
- Christopher JordanJonesboro$12K
- Amber ToombsJonesboro$12K
- Tracy ThompsonJonesboro$11K
- Ashley SheltonJonesboro$10K
- Steven VanderbiltJonesboro$10K
- Erika VanceJonesboro$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.